These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6735276)

  • 1. Automated determination of heparin with chromogenic substrates.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(2):184-94. PubMed ID: 6735276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated spectrophotometric heparin assays. Comparison of methods.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(2):195-204. PubMed ID: 6735277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of antithrombin activity by thrombin-based and by factor Xa-based chromogenic substrate assays.
    Beeck H; Nagel D; Pindur G; Scharrer I; Preiss A; Seiler D; Hellstern P
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):127-35. PubMed ID: 10759005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of low molecular weight heparin in clinical laboratory.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(2):205-10. PubMed ID: 6203817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a rapid and sensitive chromogenic heparin assay for clinical use.
    Wagenvoord RJ; Hendrix HH; Kolde HJ; Hemker HC
    Haemostasis; 1993; 23(1):26-37. PubMed ID: 8477906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of unfractionated and LMW heparin with chromogenic substrates: twin methods with factor Xa and thrombin.
    Handeland GF; Abildgaard U
    Thromb Res; 1984 Sep; 35(6):627-36. PubMed ID: 6506021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of an automated assay of effective heparin activity in plasma.
    Pierson-Perry JF; Obzansky DM; Mizzer JP
    Clin Chem; 1987 Sep; 33(9):1630-4. PubMed ID: 3621562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of thrombin generation by heparin and LMW heparins: a comparison of chromogenic and clotting methods.
    Houbouyan L; Padilla A; Gray E; Longstaff C; Barrowcliffe TW
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):24-30. PubMed ID: 8845459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238. Comparison with immunoelectrophoretic and factor Xa inhibition assays.
    Goodnight SH; Schaeffer JL; Sheth K
    Am J Clin Pathol; 1980 May; 73(5):639-47. PubMed ID: 7377131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid determination of five coagulation parameters in one sample with a centrifugal analyzer.
    Bas BM; Costongs GM; Janson PC
    Haemostasis; 1987; 17(5):260-7. PubMed ID: 3478286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915).
    Asai K; Asai M
    Clin Chim Acta; 1984 Dec; 144(2-3):163-71. PubMed ID: 6397281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of plasma serine protease chromogenic substrates.
    Bang NU; Mattler LE
    Haemostasis; 1978; 7(2-3):98-104. PubMed ID: 149051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interindividual variation in relationships between plasma heparin concentration and the results of five heparin assays.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Clin Chim Acta; 1982 Jul; 122(2):261-70. PubMed ID: 7105411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparin assay in plasma. Comparison of different methods (author's transl)].
    Vinazzer H
    Anaesthesist; 1979 Jun; 28(6):299-303. PubMed ID: 464252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood clotting diagnosis with chromogenic substrates].
    Róka L; Rasche H
    Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
    [No Abstract]   [Full Text] [Related]  

  • 19. Human alpha- and gamma-thrombin specificity with tripeptide p-nitroanalide substrates under physiologically relevant conditions.
    Witting JI; Miller TM; Fenton JW
    Thromb Res; 1987 May; 46(4):567-74. PubMed ID: 3617013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.